PathAI Partners With Datavant to Enable Biopharma Companies to Connect Digital Pathology Data for Research
PathAI and Datavant recently announced a collaboration to enable compliant connectivity of PathAI’s pathology platform to life sciences trial data and other real-world data.
PathAI’s digital platform includes 5 million specimens collected from historical biopsies and resections. PathAI applies AI and machine learning to evaluate molecular characteristics of cells for improved diagnostic precision in areas like oncology and NASH, as well as improve measurement of therapeutic effectiveness. PathAI will leverage Datavant’s compliant connectivity technology to augment their pathology insights with real-world data like electronic health records, claims, and other sources to enable granular health outcomes analyses. The partnership will also enable life sciences organizations to connect their internal trial data to the platform to increase precision in characterizing a patient’s disease and the depth of evidence on patients’ response to therapy.
“We are excited to join the Datavant ecosystem,” said Andrew H. Beck, CEO of PathAI. “The insight we can bring to researchers increases exponentially when we can compliantly connect highly granular pathology data to other rich real-world data that describes patient health status.”
“Companies like PathAI are making a previously inaccessible source of data available to life sciences organizations to accelerate drug discovery,” said Travis May, President and Founder of Datavant. “Until recently, pathology data was a physical slide of tissue accompanied by an unstructured text report. Now it is a digital piece of data that can be analyzed, and connected to other real-world data to yield unprecedented insight about disease and potential treatments.”
PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine. TFor more information, visit pathai.com.
Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of patient health records across datasets. For more information, visit www.datavant.com.
Total Page Views: 1004
